# Aspirin and Hemocompatibility Events in Chronic Advanced Heart Failure Patients With Assist Device

> **NCT06655376** · PHASE4 · RECRUITING · sponsor: **Columbia University** · enrollment: 128 (estimated)

## Conditions studied

- Bleeding
- Clot Blood

## Interventions

- **DRUG:** Aspirin
- **DRUG:** Warfarin

## Key facts

- **NCT ID:** NCT06655376
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-02
- **Primary completion:** 2027-04-01
- **Final completion:** 2027-04-01
- **Target enrollment:** 128 (ESTIMATED)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06655376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06655376, "Aspirin and Hemocompatibility Events in Chronic Advanced Heart Failure Patients With Assist Device". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT06655376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*